Accelerating research

and development of

new antibiotics and


The Netherlands Antibiotic Development Platform

The Netherlands Antibiotic Development Platform (NADP) facilitates the collaboration between public and private organisations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals.

NADP will identify relevant research groups, institutes and companies involved in chemical, biological, and/or biomedical antibiotic research to forge collaborations through targeted connections and will organise regular meetings with interested parties. At a later stage, the NADP will provide Drug Discovery Management support/vouchers and Intellectual Property and Technology Transfer Office support.


Call open: Novel Antibacterial Compounds and Therapies Antagonizing Resistance (NACTAR)

The Dutch Ministry of Ministry of Health, Welfare and Sport and NWO Domain TTW have jointly commissioned an ambitious research programme on the development of new antibiotics and alternatives to antibiotics. As a result, we present here the Call for Proposals focusing on ´Novel Antibacterial Compounds and Therapies Antagonizing Resistance’ (NACTAR). The main goal of the programme is to facilitate research and development of new antimicrobial molecules and alternatives to antibiotics, which should become available for the healthcare system for a fair and affordable price.

Only proposals that have taken part in the pre-proposal phase, will be accepted in the full proposal phase. Deadline pre-proposal phase is 27 June, 14:00 hrs.

Read more

NADP Events

NCOH Annual Scientific Meeting 2017

The meeting is aimed at researchers from NCOH Partners and Associates that are involved in all the NCOH Strategic Research Themes. Particularly young researchers (PhD students, postdocs) are encouraged to join this meeting. The theme of this symposium is “Global Solutions to One Health”.

Read more

NADP Partners